Aug. 14 at 6:08 PM
Hydrofarm 2Q25 results highlight challenges but set the stage for long-term improvements.
🔹 Revenue
$39M vs.
$42M estimate; adj. EBITDA loss
$2.3M
🔹 Restructuring to trim SKUs by one-third, driving
$3M in annual cost savings
🔹 Focus on proprietary brands (~55% of sales) & expansion into non-cannabis markets
🔹 International growth strong, led by Europe & APAC; new Spanish DC key to expansion
Management expects positive FCF over the next nine months and gross margin improvement in 2025. Continue to follow along with Dmitry Silversteyn!
https://www.watertowerresearch.com/doc?docID=UR_HYFM_08132025
$HYFM #CannabisIndustry #EquityResearch #Earnings #Agritech #GlobalExpansion #ProprietaryBrands #Ecommerce #SmallCap #Stocks #Investing #EquityMarkets